Pharma sector to remain a market favourite due to earnings visibility, say analysts

Pharma sector to remain a market favourite due to earnings visibility, say analysts

Mumbai: The healthcare index hit a record high on Friday led by a rally in sector majors Lupin, Dr Reddy’s Laboratories and Cipla on the back of positive news flow. The sector will remain a market favourite due to earnings visibility, which does not exist for most sectors currently because of the pandemic. Analysts said … Read more

Old economy stocks could be next year’s story: Jonathan Schiessl

Old economy stocks could be next year’s story: Jonathan Schiessl

It is probably worthwhile having a barbell approach in the pharma sector with mainly largecap names and maybe one or two smaller ones as well, says the Global Investment Strategist. How are you looking at the overall sentiment for the emerging markets and in particular for India? The mid and the smallcaps too have been … Read more

Don’t chase any particular sector, go bottom up: Tata Mutual Fund

Don’t chase any particular sector, go bottom up: Tata Mutual Fund

Instead of analysing valuations at a broader index level, it would make a lot of sense to look at individual companies and form your view based on the strength of their business models, says Rupesh Patel, Senior Fund Manager. How are you analysing the valuation of the broader markets?When we look at the market from … Read more

Buy IT, pharma and FMCG stocks on dips: Jai Bala

Buy  IT, pharma and FMCG stocks on dips: Jai Bala

It looks like Torrent Pharma is going to make fresh 52-week highs past Rs 3,100 and possibly even Rs 3,500, says the Chief Market Technician, cashthechaos.com How are you reading the market right now? Today it has been extremely range bound for the front line indices. Is it readying for a big breakout or some … Read more

Creador buys out Tata Capital in Shriji Polymers

Creador buys out Tata Capital in Shriji Polymers

The Kuala Lumpur based private equity firm Creador has acquired about 17% stake in Shriji Polymers- a leading packaging solution provider for global pharmaceutical industry for Rs 250 crore. Creador has bought out existing investor – Tata Capital. Creador has acquired about 13% stake held by Tata Capital and another 4% stake held by promoters. … Read more

View: Inject some blood into India’s anaemic small businesses?

View: Inject some blood into India’s anaemic small businesses?

What is also needed is to up-skill this sector and improve its ability to learn. Synopsis MSME units in India, on the other hand, have existed practically at subsistence level for decades. To move out of this morass would require a recognition that most of the sector here works with almost zero knowledge management, and … Read more

Food & drinks, pharma to be part of India-UK pact: Jayant Krishna, CEO, UKIBC

Food & drinks, pharma to be part of India-UK pact: Jayant Krishna, CEO, UKIBC

NEW DELHI: Lower tariffs on food, drinks and chemicals, along with a robust intellectual property rights (IPR) regime in India could be a few elements of the India-UK early harvest trade deal, said Jayant Krishna, Group CEO, UK-India Business Council. Krishna also said a trade deal between the UK and EU could be a prelude … Read more

Andhra announces new industrial policy with key fiscal incentives, also offers support services

Andhra announces new industrial policy with key fiscal incentives, also offers support services

HYDERABAD: Andhra Pradesh on Monday announced a new industrial development policy which seeks to offer fiscal incentives and interventions across infrastructure, ease of doing business, skill development, and business enablement, apart from setting up a multi-faceted capability center to offer support services to the units. In a statement, the government said the new multi-faceted capability … Read more

Why Vaibhav Sanghavi is extremely bearish on the market

Why Vaibhav Sanghavi is extremely bearish on the market

The PE continues to look expensive. But FY21 being washed up, people will be looking at FY22 and that is where the comfort will come from, says the Co-CEO, Avendus Capital. They say do not ask fund managers what they feel, ask them what they are doing and that tells their right position. How is … Read more

View: India needs to alter its ‘patent box’ regime as it aims for Atmanirbharta

View: India needs to alter its ‘patent box’ regime as it aims for Atmanirbharta

Atmanirbhar Bharat. These two words pack a lot of punch. The objective is to encourage domestic manufacturing, reduce reliance on imports and be globally competitive. For this, India Inc needs to innovate and invent. To boost such pursuits, several countries offer tax sops. Likewise, in 2016, a ‘patent box’ regime was introduced in India’s tax … Read more